This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mamoru Matsuura: Innovator in Pharmaceutical Chemistry
Introduction
Mamoru Matsuura is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Matsuura holds a patent for a morpholine compound, which is represented by a specific chemical formula. This compound has been identified as having an affinity for CCR3 and can be utilized in pharmaceutical products aimed at treating or preventing immune or inflammatory diseases. His innovative work in this area highlights the importance of chemical compounds in modern medicine.
Career Highlights
Matsuura is currently associated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and development efforts. His work is pivotal in the creation of new therapeutic options for patients suffering from various health conditions.
Collaborations
Throughout his career, Matsuura has collaborated with notable colleagues, including Yoshihito Tanaka and Shuzo Takeda. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical industry.
Conclusion
Mamoru Matsuura's contributions to pharmaceutical chemistry, particularly through his patented morpholine compound, underscore his role as a key innovator in the field. His ongoing work at Mitsubishi Tanabe Pharma Corporation continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile